Infective Endocarditis - PowerPoint PPT Presentation

1 / 26
About This Presentation
Title:

Infective Endocarditis

Description:

... Duke criteria Major & minor Sensitivity about 90% Table 145-3 differential diagnosis Viral illnesses HIV-related fevers Acute rheumatic fever Systemic ... – PowerPoint PPT presentation

Number of Views:27
Avg rating:3.0/5.0
Slides: 27
Provided by: hmis0
Learn more at: http://www.sjem.org
Category:

less

Transcript and Presenter's Notes

Title: Infective Endocarditis


1
Infective Endocarditis
  • Tintinallis Chap. 145

2
epidemiology
  • Incidence ranges from 2.4 to 11.9 cases per
    100,000 patient-years
  • Higher in urban vs. rural populations
  • 25 of cases in pts lt 30 y.o.
  • 50 of cases in pts ages 31-60
  • 25 of cases in pts gt 60 y.o.
  • Uncommon in kids
  • Related primarily to congenital heart dz,
    rheumatic heart dz, or nosocomial
  • Aortic valve most commonly affected
  • Then mitral, tricuspid, pulmonic valves

3
risk factors
  • IVDA
  • Indwelling catheters (vascular)
  • Poor dental hygiene
  • HIV
  • Prosthetic heart valves
  • Risk greatest in first 6 mos after surgery
  • MVP (most common predisposing cardiac lesion)
  • Rheumatic heart dz still leading RF in developing
    countries

4
pathophysiology
  • Normal endothelium is resistant to infxn
    thrombus formation
  • Turbulent blood flow damage to
    endocardium/endothelium
  • Endothelial damage promotes deposition of
    platelets fibrin
  • Form sterile vegetations called nonbacterial
    thrombotic endocarditis (NBTE)

5
pathophysiology
  • Transient bacteremia may result in colonization
    of vegetations conversion of NBTE to IE
  • Highly invasive orgs like S. aureus can also
    directly invade the endocardium and stimulate the
    adherence of platelets fibrin

6
(No Transcript)
7
microbiology
  • Table 145-1
  • Bacteria are most common cause
  • S. aureus is most common bacteria
  • Fungi, Rickettsia, Chlamydia species

8
native valve endocarditis
  • Non-IVDA
  • Streptococcus is org in gt 50 of cases
  • Then staph enterococci
  • Preexisting valvular abnormalities
  • Rapid destruction of valves
  • Multiple distal abscesses
  • Myocardial abscesses
  • Conduction defects
  • Pericarditis
  • May have negative blood cxs

9
IVDA-associated IE
  • Contaminants include normal skin flora or
    injection devices
  • S. aureus (gt50 of cases)
  • Then strep, enterococci, gm-neg bacilli like
    Pseudomonas, fungi (Candida)

10
prosthetic valve endocarditis
  • Contamination during perioperative period
  • S. epidermidis
  • Then strep, aspergillus candida
  • Valve dysfunction
  • Fulminant clinical course

11
clinical features
  • Acute
  • Rapid onset
  • High fever/rigors
  • Hemodynamic deterioration
  • Death
  • S. aureus

12
clinical features
  • Subacute
  • Indolent course
  • Progressive constitutional sxs
  • Gradual deterioration
  • S. viridans
  • See Table 145-2

13
clinical features
  • Bacteremia
  • Heat murmurs
  • In right-sided IE lt50 of pts have detectable
    murmurs on admission
  • CHF (leading cause of death in IE)
  • Valvular abscesses
  • Pericarditis
  • Heart blocks arrhythmias
  • Distal embolisms (bland or septic)

14
clinical features
  • Stroke (MCA most common)
  • SAH
  • Retinal artery emboli (monocular blindness)
  • Pulmonary infarction
  • Pneumonia
  • Empyema
  • Pleural effusions
  • MI
  • Myocarditis
  • Splenic infarction
  • Renal emboli
  • Mesenteric emboli
  • Acute limb ischemia

15
Janeway lesions
16
Osler nodes
17
Roth spots
18
diagnosis
  • Duke criteria
  • Major minor
  • Sensitivity about 90
  • Table 145-3

19
(No Transcript)
20
(No Transcript)
21
differential diagnosis
  • Viral illnesses
  • HIV-related fevers
  • Acute rheumatic fever
  • Systemic complications of collagen vascular
    disorders
  • Drug reactions

22
evaluation
  • Blood cxs (done in ED!)
  • Prior to axbx
  • 3 separate sites
  • 1 hr between 1st last set
  • EKG
  • CXR
  • CBC
  • ESR
  • U/A
  • Echo

23
(No Transcript)
24
treatment prophylaxis
  • ABCs
  • Empiric axbx
  • Native valve IE
  • Penicillinase-resistant penicillin or
    cephalosporin aminoglycoside
  • Pts w/ complications (IVDA, CHD)
  • Add vancomycin to above regimen
  • Table 145-5

25
treatment prophylaxis
  • Empiric axbx cont.
  • PVE
  • Vancomycin aminoglycoside rifampin
  • Definitive axbx tx as soon as cxs reveal
    causative orgs
  • Tx for 4-6 wks
  • Surgical tx for sev. valvular dysfxn.
  • Acute CHF or hemodynamic instability

26
treatment prophylaxis
  • Axbx given to pts with RFs for endocarditis (see
    Table 145-6)
  • Pts w/ prosthetic heart valves, congenital
    cardiac malformations, acquired valvular
    dysfunction, hypertrophic cardiomyopathy, MVP w/
    documented regurgitation or hx of endocarditis
  • Procedures include dental work, bronchoscopy,
    cystoscopy, urethral instrumentation ERCP
Write a Comment
User Comments (0)
About PowerShow.com